Novartis stock popped Wednesday after the Swiss pharmaceutical giant raised its 2019 outlook, noting three potential blockbuster drugs are on track.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,